聯(lián)系我們時(shí)請(qǐng)說(shuō)明是91化工儀器網(wǎng)上看到的信息,謝謝!
產(chǎn)品簡(jiǎn)介 品牌 MedChemExpress (MCE) 貨號(hào) HY-32721 規(guī)格 10 mM * 1 mL;5 mg;10 mg 供貨周期 現(xiàn)貨 應(yīng)用領(lǐng)域 生物產(chǎn)業(yè) Neratinib 是一種可口服的,不可逆的 tyrosine kinase 抑制劑,能夠抑制 HER2 和 EGFR 的活性,IC50 值分別為 59 nM 和 92 nM。
詳細(xì)介紹 Neratinib
產(chǎn)品活性:Neratinib 是一種可口服的,不可逆的 tyrosine kinase 抑制劑,能夠抑制 HER2 和 EGFR 的活性,IC50 值分別為 59 nM 和 92 nM。
研究領(lǐng)域:JAK/STAT Signaling | Protein Tyrosine Kinase/RTK
作用靶點(diǎn):EGFR
In Vitro: Neratinib has inhibition of tyrosine kinases KDR and Src with IC50 of 0.8 μM and 1.4 μM, respectively, being 14- and 24-fold less active compared with HER2. Neratinib displays no activity against other serine-threonine kinases such as Akt, cyclin D1/cdk4, cyclin E/cdk2, cyclin B1/cdk1, IKK-2, MK-2, PDK1, c-Raf, and Tpl-2, as well as the tyrosine kinase c-Met. Neratinib selectively inhibits the proliferation of 3T3 cells transfected with the HER2 (3T3/neu), as well as two other HER-2-overexpressing SK-Br-3 and BT474 cells with IC50 values of 2-3 nM, displaying > 230-fold potency compared with non-transfected 3T3 cells as well as MDA-MB-435 and SW620 which are EGFR- and HER2-negative. Neratinib also inhibits the proliferation of EGFR-dependent A431 cells with an IC50 of 81 nM. Neratinib reduces HER2 receptor autophosphorylation in BT474 cells with an IC50 of 5 nM, and EGF-dependent phosphorylation of EGFR in A431 cells with IC50 of 3 nM. Blocking of HER-2 by Neratinib results in inhibition of downstream MAPK and Akt pathways with IC50 of 2 nM, more potently than Trastuzumab. Neratinib inhibits the cyclin D1 expression and the phosphorylation of the Rb-susceptibility gene production in BT474 cells with IC50 of 9 nM, leading to G1-S arrest and ultimately decreased cell proliferation.
In Vivo: Orally treated neratinib significantly inhibits the growth of 3T3/neu xenografts, with inhibition of 34%, 53%, 98%, and 98% at dose of 10, 20, 40, and 80 mg/kg/day, respectively. Consistent with the inhibition of HER-2 phosphorylation by 84% within 1 hour of administration at 40 mg/kg/day, Neratinib inhibits the growth of BT474 xenografts by 70-82%, 67%, and 93% at dose of 5, 10, and 40 mg/kg/day, respectively. Neratinib is also effective against SK-OV-3 xenografts with inhibition of 31% and 85% at 5 and 60 mg/kg/day, respectively. Neratinib is less potent against EGFR-dependent A431 xenografts than HER-2-dependent tumors, with 32% and 44% inhibition at 5 and 20 mg/kg/day, respectively. Neratinib displays little activity against MCF-7 and MX-1 xenografts expressing low levels of HER-2 and EGFR, with only 28% inhibition at 80 mg/kg/day, suggesting that Neratinib has selective activity for cells expressing HER-2 or EGFR.
相關(guān)產(chǎn)品:Drug Repurposing Compound Library | Kinase Inhibitor Library | JAK/STAT Compound Library | Clinical Compound Library | Clinical Compound Library Plus | Protein Tyrosine Kinase Compound Library | Anti-Cancer Compound Library | Drug Repurposing Compound Library Plus | Bioactive Compound Library Plus | Osimertinib | Gefitinib | Afatinib | Erlotinib | AG-490 | Lapatinib | Trastuzumab | Cetuximab | (-)-Epigallocatechin Gallate | Genistein | Dacomitinib | AG-1478 | Poziotinib | Sapitinib | Tucatinib | Pyrotinib | BMS-690514 | TAS6417 | Mubritinib | Olmutinib | Canertinib dihydrochloride | Icotinib | AZD3759 | Tyrphostin 23 | Pelitinib
以上信息由企業(yè)自行提供,信息內(nèi)容的真實(shí)性、準(zhǔn)確性和合法性由相關(guān)企業(yè)負(fù)責(zé),91化工儀器網(wǎng)對(duì)此不承擔(dān)任何保證責(zé)任。溫馨提示:為規(guī)避購(gòu)買風(fēng)險(xiǎn),建議您在購(gòu)買產(chǎn)品前務(wù)必確認(rèn)供應(yīng)商資質(zhì)及產(chǎn)品質(zhì)量。 搜本商鋪 或 搜全站
MedChemExpress LLC - 主營(yíng)產(chǎn)品: 西羅莫司 Rapamycin,瑞沙托維 TAK-242,奧拉帕尼 Olaparib
地址:上海市浦東新區(qū)張衡路1999弄3號(hào)樓 聯(lián)系電話:86-021-58955995 手機(jī):18019480960 傳真:86-021-5370032591化工儀器網(wǎng) 設(shè)計(jì)制作,未經(jīng)允許翻錄必究 . Copyright(C) http://www.chem17.com, All rights reserved. 以上信息由企業(yè)自行提供,信息內(nèi)容的真實(shí)性、準(zhǔn)確性和合法性由相關(guān)企業(yè)負(fù)責(zé),91化工儀器網(wǎng)對(duì)此不承擔(dān)任何保證責(zé)任。
溫馨提示:為規(guī)避購(gòu)買風(fēng)險(xiǎn),建議您在購(gòu)買產(chǎn)品前務(wù)必確認(rèn)供應(yīng)商資質(zhì)及產(chǎn)品質(zhì)量。
會(huì)員登錄